|
Market Closed -
Nasdaq Stockholm
20:00:00 27/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 2.020 SEK | +3.80% |
|
+1.92% | +2.54% |
| 02:21pm | Irlab Therapeutics Set to Obtain US Patent for Parkinson's Disease Drug Candidate | MT |
| 09:04am | Irlab receives positive patent notice in the US for IRL1117 | FW |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 29.07M | - | - | - | ||
| 1,140B | |||||
| 641B | |||||
| 507B | |||||
| 383B | |||||
| 347B |
Select your edition
All financial news and data tailored to specific country editions
